null Nadine Kronfli, MD, MPH, FRCP(C), DTM&H
HIV • hepatitis C • COVID-19 • vulnerable populations • people in prison • migrants • implementation science • evidence-based policies
My research focuses on designing, deploying, and evaluating evidence-based models of care that aim to increase engagement along the HIV and hepatitis C virus care cascades for vulnerable populations, with a particular focus on incarcerated and migrant populations. During the COVID-19 pandemic, my research has expanded to include seroprevalence studies in correctional facilities and interventions to increase COVID-19 vaccine uptake among people in prison. The ultimate goal of my research is to support the development of evidence-based policies to improve population health with an emphasis on eliminating certain infectious diseases such as hepatitis C and SARS-CoV-2 among neglected populations.
Kronfli N, Bhatnagar S, Hull M, et al. Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up. AIDS 2019; January.
Kronfli N, Nitulescu R, Cox J, et al. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada. J Int AIDS Soc 2018; 21(11): e25197.
Kronfli N, Linthwaite B, Kouyoumdjian F, et al. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review. Int J Drug Policy 2018; 57: 95-103.
Kronfli N, Cox J. Care for people with hepatitis C in provincial and territorial prisons. CMAJ 2018; 190(4): E93-E4.
Kronfli N, Lacombe-Duncan A, Wang L, et al. Understanding the correlates of attrition associated with antiretroviral use and viral suppression among women living with HIV in Canada. AIDS Patient Care and STDs 2017; 31(10) 428-437.